Select Publications
Preprints
2024, Rationale, Design, and Intervention Development of a Mobile Health–Led Primary Care Program for Management of Type 2 Diabetes in Rural Thailand: Protocol for a SMARThealth Diabetes Study (Preprint), http://dx.doi.org/10.2196/preprints.59266
,2024, International prevalence patterns of low eGFR in adults aged 18-60 without traditional risk factors from population-based cross-sectional studies: a disadvantaged populations eGFR epidemiology (DEGREE) study, http://dx.doi.org/10.1101/2024.06.24.24309380
,2023, A community-based intervention to improve screening, referral, and follow-up of non-communicable diseases and anaemia amongst pregnant and postpartum women in rural India: study protocol for a cluster randomised trial, http://dx.doi.org/10.21203/rs.3.rs-2938523/v1
,2023, PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V), http://dx.doi.org/10.21203/rs.3.rs-2367788/v1
,2023, Prophylaxis for Patients at Risk of COVID-19 Infection: Results from the Intranasal Niclosamide Randomised, Double Blinded, Placebo Controlled Arm of the PROTECT-V Platform Trial, http://dx.doi.org/10.2139/ssrn.4519538
,2022, A Mobile Clinical Decision Support System for High-Risk Pregnant Women in Rural India (SMARThealth Pregnancy): Pilot Cluster Randomized Controlled Trial (Preprint), http://dx.doi.org/10.2196/preprints.44362
,2022, ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial, http://dx.doi.org/10.21203/rs.3.rs-1045085/v1
,2022, Heterogeneity of treatment effect of higher dose dexamethasone by geographic region in patients with COVID-19 and severe hypoxemia - Apost hocevaluation of the COVID STEROID 2 trial, http://dx.doi.org/10.1101/2022.11.23.22282463
,2021, Access to and Barriers to Access for Essential Medicines in Nephrology and Related Non-Communicable Diseases: A Scoping Review Protocol, http://dx.doi.org/10.21203/rs.3.rs-1173063/v1
,2021, Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial, http://dx.doi.org/10.1101/2021.08.17.21262196
,2021, Hydroxychloroquine Plus Standard Personal Protective Equipment Versus Standard Personal Protective Equipment Alone for the Prevention of Laboratory Confirmed Covid-19 Infections Among Healthcare Workers: A Multi-Centre Parallel Group Randomized Controlled Trial from India, http://dx.doi.org/10.2139/ssrn.3927782
,2019, Access to CKD Care in Rural Communities of India: A Qualitative Study Exploring the Barriers and Facilitators, http://dx.doi.org/10.21203/rs.2.16182/v1
,